Related Experiment Video
Updated: May 8, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
MicroRNAs may solve the mystery of chronic hepatitis B virus infection
Ying-Feng Wei1, Guang-Ying Cui, Ping Ye
1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medical, Zhejiang University, Hangzhou 310003, Zhejiang Province, China.
Insights
Hepatitis B virus (HBV) infection causes severe liver disease. MicroRNAs (miRNAs) are key in HBV interaction, potentially serving as diagnostic biomarkers and therapeutic targets for better treatment outcomes.
Area of Science:
- Hepatology
- Molecular Biology
- Virology
Background:
- Hepatitis B virus (HBV) infection is a major global health concern, leading to chronic liver diseases like cirrhosis and hepatocellular carcinoma.
- The precise pathogenesis of HBV-related diseases remains unclear, and current treatments are suboptimal.
- MicroRNAs (miRNAs), small noncoding RNAs regulating gene expression, are increasingly recognized for their role in physiological and pathological processes, including host-virus interactions.
Purpose of the Study:
- To explore the role of microRNAs (miRNAs) in Hepatitis B virus (HBV) infection and associated liver diseases.
- To investigate miRNAs as potential biomarkers for HBV diagnosis and prognosis.
- To assess the therapeutic potential of miRNA-based strategies for HBV-related conditions.
Main Methods:
- Review of existing literature on miRNA expression patterns in HBV infection.
- Analysis of studies investigating the involvement of differentially expressed miRNAs in HBV pathogenesis, including liver tumorigenesis and metastasis.
- Examination of research on circulating miRNAs as diagnostic and prognostic markers.
- Evaluation of preclinical and clinical studies on miRNA-based therapeutic approaches for HBV.
Main Results:
- HBV infection alters cellular miRNA expression profiles, with distinct miRNA signatures observed at different disease stages.
- Specific miRNAs are implicated in the progression of HBV-related liver diseases, including liver cancer development and spread.
- Circulating miRNAs in serum or plasma show promise as non-invasive biomarkers for diagnosing and predicting the prognosis of HBV-related diseases.
- miRNA-based therapies are emerging as a promising future direction for treating HBV-related conditions.
Conclusions:
- MicroRNAs play a significant role in the host-HBV interaction and the pathogenesis of HBV-related liver diseases.
- miRNAs represent valuable biomarkers for the diagnosis and prognosis of HBV infection.
- miRNA-targeted therapies offer a promising avenue for the future treatment of Hepatitis B virus-related diseases.
Abstract:
Hepatitis B virus (HBV) infection is a global public health problem that causes persistent liver diseases such as chronic hepatitis, cirrhosis, and hepatocellular carcinoma. A large amount of people die annually from HBV infection. However, the pathogenesises of the HBV-related diseases are ill defined and the therapeutic strategies for the diseases are less than optimum. The recently discovered microRNAs (miRNAs) are tiny noncoding RNAs that regulate gene expression primarily at the post-transcriptional level by binding to mRNAs. miRNAs contribute to a variety of physiological and pathological processes. A number of miRNAs have been found to play a pivotal role in the host-virus interaction including host-HBV interaction. Numerous studies have indicated that HBV infection could change the cellular miRNA expression patterns and different stages of HBV associated disease have displayed distinctive miRNA profiles. Furthermore, the differential expressed miRNAs have been found involved in the progression of HBV-related diseases, for instance some miRNAs are involved in liver tumorigenesis and tumor metastasis. Studies have also shown that the circulating miRNA in serum or plasma might be a very useful biomarker for the diagnosis and prognosis of HBV-related diseases. In addition, miRNA-based therapy strategies have attracted increasing attention, indicating a promising future in the treatment of HBV-related diseases.
Related Concept Videos
Hepatitis
Viruses with RNA Genomes
Viral Hepatitis I: Introduction
Human Virome
MicroRNAs
MicroRNAs

